Background: Plasmodium falciparum apical membrane antigen-1 (AMA1) is a leading malaria vaccine candidate antigen that is expressed by sporozoite, liver and blood stage parasites. Since CD8+ T cell responses have been implicated in protection against pre-erythrocytic stage malaria, this study was designed to identify MHC class I-restricted epitopes within AMA1. Methods: A recombinant adenovirus serotype 5 vector expressing P. falciparum AMA1 was highly immunogenic when administered to healthy, malaria-naive adult volunteers as determined by IFN-γ ELISpot responses to peptide pools containing overlapping 15-mer peptides spanning full-length AMA1. Computerized algorithms (NetMHC software) were used to predict minimal MHC-restricted 8-10-me...
Malaria is a global health burden, and a major cause of mortality and morbidity in Africa. Here we d...
Malaria is a global health burden, and a major cause of mortality and morbidity in Africa. Here we d...
Apical Membrane Antigen 1 (AMA1) is a leading malaria vaccine candidate and a target of naturally-ac...
Background: Plasmodium falciparum apical membrane antigen-1 (AMA1) is a leading malaria vaccine cand...
Background: Plasmodium falciparum circumsporozoite protein (CSP) is a leading malaria vaccine candid...
Background: Plasmodium falciparum circumsporozoite protein (CSP) is a leading malaria vaccine candid...
Background: Plasmodium falciparum circumsporozoite protein (CSP) is a leading malaria vaccine candid...
Background: Plasmodium falciparum circumsporozoite protein (CSP) is a leading malaria vaccine candid...
Control of malaria is an important global health issue and there is still an urgent need for the dev...
We recently identified novel Plasmodium berghei (Pb) liver stage (LS) genes that as DNA vaccines sig...
BACKGROUND: Two long synthetic peptides representing the dimorphic and constant C-terminal domains o...
BACKGROUND: Technical limitations for culturing the human malaria parasite Plasmodium vivax have imp...
Although Plasmodium falciparum apical membrane antigen 1 (AMA1) is a leading malaria vaccine candida...
BACKGROUND: Two long synthetic peptides representing the dimorphic and constant C-terminal domains o...
Serum antibodies from 1071 people in two Kenyan villages were assayed using eight different recombin...
Malaria is a global health burden, and a major cause of mortality and morbidity in Africa. Here we d...
Malaria is a global health burden, and a major cause of mortality and morbidity in Africa. Here we d...
Apical Membrane Antigen 1 (AMA1) is a leading malaria vaccine candidate and a target of naturally-ac...
Background: Plasmodium falciparum apical membrane antigen-1 (AMA1) is a leading malaria vaccine cand...
Background: Plasmodium falciparum circumsporozoite protein (CSP) is a leading malaria vaccine candid...
Background: Plasmodium falciparum circumsporozoite protein (CSP) is a leading malaria vaccine candid...
Background: Plasmodium falciparum circumsporozoite protein (CSP) is a leading malaria vaccine candid...
Background: Plasmodium falciparum circumsporozoite protein (CSP) is a leading malaria vaccine candid...
Control of malaria is an important global health issue and there is still an urgent need for the dev...
We recently identified novel Plasmodium berghei (Pb) liver stage (LS) genes that as DNA vaccines sig...
BACKGROUND: Two long synthetic peptides representing the dimorphic and constant C-terminal domains o...
BACKGROUND: Technical limitations for culturing the human malaria parasite Plasmodium vivax have imp...
Although Plasmodium falciparum apical membrane antigen 1 (AMA1) is a leading malaria vaccine candida...
BACKGROUND: Two long synthetic peptides representing the dimorphic and constant C-terminal domains o...
Serum antibodies from 1071 people in two Kenyan villages were assayed using eight different recombin...
Malaria is a global health burden, and a major cause of mortality and morbidity in Africa. Here we d...
Malaria is a global health burden, and a major cause of mortality and morbidity in Africa. Here we d...
Apical Membrane Antigen 1 (AMA1) is a leading malaria vaccine candidate and a target of naturally-ac...